美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA086513"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
0378-0403-01 0378-0403 HUMAN PRESCRIPTION DRUG Spironolactone and Hydrochlorothiazide spironolactone and hydrochlorothiazide TABLET ORAL 19790803 N/A ANDA ANDA086513 Mylan Pharmaceuticals Inc. HYDROCHLOROTHIAZIDE; SPIRONOLACTONE 25 mg/1; 25 mg/1 100 TABLET in 1 BOTTLE, PLASTIC (0378-0403-01)
0378-0403-05 0378-0403 HUMAN PRESCRIPTION DRUG Spironolactone and Hydrochlorothiazide spironolactone and hydrochlorothiazide TABLET ORAL 19790803 N/A ANDA ANDA086513 Mylan Pharmaceuticals Inc. HYDROCHLOROTHIAZIDE; SPIRONOLACTONE 25 mg/1; 25 mg/1 500 TABLET in 1 BOTTLE, PLASTIC (0378-0403-05)
42292-017-20 42292-017 HUMAN PRESCRIPTION DRUG Spironolactone and Hydrochlorothiazide spironolactone and hydrochlorothiazide TABLET ORAL 20170512 N/A ANDA ANDA086513 Mylan Institutional Inc. HYDROCHLOROTHIAZIDE; SPIRONOLACTONE 25 mg/1; 25 mg/1 100 BLISTER PACK in 1 CARTON (42292-017-20) / 1 TABLET in 1 BLISTER PACK (42292-017-01)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase